01-02-2023 | Omalizumab | Case report
Ad26.COV2-S/omalizumab
Idiopathic bradykinin-mediated angioedema and lack of efficacy: case report
Published in: Reactions Weekly | Issue 1/2023
Login to get accessExcerpt
Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event